• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Avel eCare Acquires Virtual Hospitalist Provider Fident Health

Share:

September 25, 2023

Avel eCare, a clinician-to-clinician telemedicine services provider, has acquired Fident Health, a virtual hospitalist provider in Texas. The acquisition expands Avel eCare’s clinician network and enhances its telemedicine offerings for hospitals, health systems, and senior care facilities in rural and suburban areas, enabling them to provide high-quality care to their communities. Together, the companies will serve more than 220 senior care facilities and over 350 hospitals across the United States. Financial terms of the deal were not disclosed.

What You Should Know:

Avel eCare, a provider of clinician-to-clinician telemedicine services acquires Fident Health, a Texas-based virtual hospitalist provider dedicated to delivering high-quality telemedicine care to rural and suburban communities.

– The acquisition strengthens Avel eCare’s existing clinician network and builds on the company’s successful acute and post-acute telemedicine solutions to help hospitals, health systems and senior care facilities throughout the United States deliver state-of-the-art care to their communities.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Acquisition Impact

Fident Health brings its highly experienced clinical team to augment Avel eCare’s successful hospitalist and senior care services. Combined, the two companies will serve over 220 Senior Care Facilities and over 350 hospitals (community, regional and critical care hospitals) across the country. Financial details of the acquisition were not disclosed.

Source: HitConsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease CompanyOvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
  • Merck Cements Dedication to Cardiovascular Disease with $11.5 Acceleron AcquisitionMerck Cements Dedication to Cardiovascular Disease with $11.5 Acceleron Acquisition
  • Danaher to acquire Abcam for $24.00 per ShareDanaher to acquire Abcam for $24.00 per Share
  • Highmark Health Taps Verily to Build Digital Health Tools for Living Health ModelHighmark Health Taps Verily to Build Digital Health Tools for Living Health Model
  • Partners in Digital Health Need to be Clear on the ’give-get’ RelationshipPartners in Digital Health Need to be Clear on the ’give-get’ Relationship
  • Cantel Acquires Vista Research GroupCantel Acquires Vista Research Group
  • Quibim Works with Highlight Therapeutics to Improve Immunotherapy in Melanoma with AIQuibim Works with Highlight Therapeutics to Improve Immunotherapy in Melanoma with AI
  • Philips Partners With Proscia to Accelerate Open Digital Pathology Adoption

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications